ConductScience.org, home

Paper14970397

Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles.

Chan J and 4 others. RNA, 2004. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles. Papers, record 14970397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14970397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles.
PubMed
Journal
RNA
PubMed
Year
2004
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
1.03
iCite
Revised in PubMed
2024-03-14
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chan JJenny
2Khan SNShakila N
3Harvey IIsabelle
4Merrick WWilliam
5Pelletier JJerry

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Eukaryotic CellsMajor topic
Protein BiosynthesisMajor topic
Protein Synthesis InhibitorsMajor topic
Algorithms
Benzofurans
Diterpenes
Dose-Response Relationship, Drug
Genes, Reporter
Glycosides
HeLa Cells
Humans
Polyribosomes
Sesquiterpenes
Spiro Compounds

Source PubMed

Download CSV of topics

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17619818Mechanism of protein synthesis inhibition by didemnin B in vitro.Biochemistry1995https://conductscience.org/library/papers/7619818PubMed
22720652Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.Cancer Res1989https://conductscience.org/library/papers/2720652PubMed
33698162Disposition and metabolism of the antitumor glycoside phyllanthoside in mouse and beagle dog.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3698162PubMed
42204626Nucleotide sequence, expression, and properties of luciferase coded by lux genes from a terrestrial bacterium.J Biol Chem1990https://conductscience.org/library/papers/2204626PubMed
5221915Codon-anticodon interaction at the ribosomal P (peptidyl-tRNA)site.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/221915PubMed
66197992Inhibition of protein synthesis in CHO cells by actinomycin D: lesion occurs after 40S initiation complex formation.Biochemistry1983https://conductscience.org/library/papers/6197992PubMed
712403465Inhibition of protein synthesis by aminoglycoside-arginine conjugates.RNA2002https://conductscience.org/library/papers/12403465PubMed
85965321Synthesis of ribonucleic acid in L cells during inhibition of protein synthesis by cycloheximide.Mol Pharmacol1966https://conductscience.org/library/papers/5965321PubMed
97741767Site of action of two novel pyrimidine biosynthesis inhibitors accurately predicted by the compare program.Biochem Pharmacol1995https://conductscience.org/library/papers/7741767PubMed
105707707Guanosine triphosphate dependent enzymic binding of aminoacyl transfer ribonucleic acid to yeast ribosomes.Eur J Biochem1968https://conductscience.org/library/papers/5707707PubMed
114343427Mode of action of tylocrebrine: effects on protein and nucleic acid synthesis.Mol Pharmacol1972https://conductscience.org/library/papers/4343427PubMed
1211824527An antiproliferative norditerpene dilactone, Nagilactone C, from Podocarpus neriifolius.Phytomedicine2001https://conductscience.org/library/papers/11824527PubMed
131175595Effects of ricin on the ribosomal sites involved in the interaction of the elongation factors.Eur J Biochem1975https://conductscience.org/library/papers/1175595PubMed
141240811Antitumor activity of nagilactones.Gan1975https://conductscience.org/library/papers/1240811PubMed
159988267The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia.Nat Genet1999https://conductscience.org/library/papers/9988267PubMed
1611953842Translation initiation and its deregulation during tumorigenesis.Br J Cancer2002https://conductscience.org/library/papers/11953842PubMed
175907359Inhibitory effects of acetoxycycloheximide, puromycin, and pactamycin upon synthesis of protein and DNA in asynchronous populations of HeLa cells.Mol Pharmacol1966https://conductscience.org/library/papers/5907359PubMed
1810608919Antitumor compounds from tunicates.Med Res Rev2000https://conductscience.org/library/papers/10608919PubMed
1910585489Translational regulation of ribonucleotide reductase by eukaryotic initiation factor 4E links protein synthesis to the control of DNA replication.J Biol Chem1999https://conductscience.org/library/papers/10585489PubMed
2011050335Internal ribosome initiation of translation and the control of cell death.Trends Genet2000https://conductscience.org/library/papers/11050335PubMed

See all 56 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
37860121
YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy.
Front Pharmacol2023https://conductscience.org/library/papers/37860121PubMed
37537169Molecular basis of the pleiotropic effects by the antibiotic amikacin on the ribosome.Nat Commun2023https://conductscience.org/library/papers/37537169PubMed
36982256Anticancer Small-Molecule Agents Targeting Eukaryotic Elongation Factor 1A: State of the Art.Int J Mol Sci2023https://conductscience.org/library/papers/36982256PubMed
35589706Ribosome inhibition by C9ORF72-ALS/FTD-associated poly-PR and poly-GR proteins revealed by cryo-EM.Nat Commun2022https://conductscience.org/library/papers/35589706PubMed
35525914Pharmacogenomics of in vitro response of the NCI-60 cancer cell line panel to Indian natural products.BMC Cancer2022https://conductscience.org/library/papers/35525914PubMed
35184897Spatiotemporally resolved protein synthesis as a molecular framework for memory consolidation.Trends Neurosci2022https://conductscience.org/library/papers/35184897PubMed
34503202Inhibition of the Eukaryotic 80S Ribosome as a Potential Anticancer Therapy: A Structural Perspective.Cancers (Basel)2021https://conductscience.org/library/papers/34503202PubMed
34251165Identifying the Cellular Target of Cordyheptapeptide A and Synthetic Derivatives.ACS Chem Biol2021https://conductscience.org/library/papers/34251165PubMed
33996904Hiding in Plain Sight: Formation and Function of Stress Granules During Microbial Infection of Mammalian Cells.Front Mol Biosci2021https://conductscience.org/library/papers/33996904PubMed
33862007The nucleolus as a polarized coaxial cable in which the rDNA axis is surrounded by dynamic subunit-specific phases.Curr Biol2021https://conductscience.org/library/papers/33862007PubMed
33289002Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19.Heliyon2020https://conductscience.org/library/papers/33289002PubMed
33280581A Quick Guide to Small-Molecule Inhibitors of Eukaryotic Protein Synthesis.Biochemistry (Mosc)2020https://conductscience.org/library/papers/33280581PubMed
33034879Anticancer Activities and Mechanism of Action of Nagilactones, a Group of Terpenoid Lactones Isolated from Podocarpus Species.Nat Prod Bioprospect2020https://conductscience.org/library/papers/33034879PubMed
30541569The Plasmodium falciparum cytoplasmic translation apparatus: a promising therapeutic target not yet exploited by clinically approved anti-malarials.Malar J2018https://conductscience.org/library/papers/30541569PubMed
28457705Inhibition of Eukaryotic Translation by the Antitumor Natural Product Agelastatin A.Cell Chem Biol2017https://conductscience.org/library/papers/28457705PubMed
28322844A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis.Eur J Pharmacol2017https://conductscience.org/library/papers/28322844PubMed
27592390Design of nucleotide-mimetic and non-nucleotide inhibitors of the translation initiation factor eIF4E: Synthesis, structural and functional characterisation.Eur J Med Chem2016https://conductscience.org/library/papers/27592390PubMed
27528614Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer Cells.Mol Cell Biol2016https://conductscience.org/library/papers/27528614PubMed
25209664Structural basis for the inhibition of the eukaryotic ribosome.Nature2014https://conductscience.org/library/papers/25209664PubMed
24974795Translational control of mGluR-dependent long-term depression and object-place learning by eIF2α.Nat Neurosci2014https://conductscience.org/library/papers/24974795PubMed

See all 33 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14970397

GET https://conductscience.org/api/papers/v1/14970397/references?page=2